Skip to main content
OpenTrials
Recruiting

NCT Number: NCT00932594

The New Serial Treatment of Temporomandibular Disorders

The purpose of this study is to look at temporomandibular joint (TMJ) pressure as a guideline to analyze the different treatments for temporomandibular disorder (TMD), and judge the feasibility of the adjust TMJ pressure treatment and to reach a conclusion on the different treatments for different types of TMD, and determine the new serial treatment of temporomandibular disorders.

Recruiting

Interested in participating?

Request Info

Key information

Age range

16 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Guanghua School of Stomatology and Hospital of Stomatology

Guangzhou, Guangdong, China

Location status: Recruiting

Location contact

zg zhang, Master

CONTACT

[email protected]

8602083870387

About this study

Temporomandibular Disorder is a common disease nowadays, but there is no guideline for the treatment of TMD. TMD can be divided into masticating muscles dysfunction; internal derangement; inflammation; osteoarthrosis, this study will classify the internal derangement, inflammation and osteoarthrosis into three types according to the TMJ pressure. Then the patient will receive the adjust pressure treatment according to their TMJ pressure. The first part of the TMD patients will receive psychogenic treatment, medicine, physical treatment, bite plate, occlusion treatment, rebuilding occlusion treatment, orthodontic treatment, et. If the patients do not have a good curative effect, part of them will change the treatment into arthrocentesis, arthroscopic treatment or operation treatment, the other part of patients, according to their TMJ pressure, receiving the associated adjust pressure treatment or adjust pressure treatment only. This study will call on the patients for three years and collect the clinical information, then doing the medical statistics.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Limited Month Opening
  • Abnormal of the Month Opening Type
  • Paint During the Month Open or Close
  • Condylar Position Paint
  • Clicking of the Temporomandibular Joint
  • Enlargement of the Upper Temporomandibular Joint Gap
  • Dislocation of the Temporomandibular Disc
  • Bone of the Temporomandibular Joint Changement
  • Patient in the Age of 16-60
  • Voluntary Patient

Exclusion criteria

  • Dysimmunity Disease
  • Dysfunction of Heart Liver and Kidney Disease
  • Patient can not do the Guide Line
  • Life-threatening Patient
  • Serious Limited Mouth Opening
  • Epilepsy
  • Tetanus
  • Pregnancy or Women in the Pregnancy Period
  • Supportive Temporomandibular Disease

Treatment and study plan

Adjust the TMJ Pressure to Normal Value

Procedure

Adjust the TMJ Pressure by the Operation Only Once for Each Patient

Do not adjust the pressure of TMJ

Other

Do the treatments normally without additional treatment

Primary outcomes

  1. all cause mortality

    Time frame: 24 hours

Study contacts

Contact information is provided by the study sponsor or research team.

zg zhang, Master

CONTACT

[email protected]

8602083870387

Sponsors and collaborators

Lead sponsor

Sun Yat-sen University

Other

Registry information

Official study title

Create the New Serial Treatment of Temporomandibular Disorders

Important dates

Study start
2006
Primary completion
2018
Study completion
2026
First posted
Jul 3, 2009
Registry last updated
May 20, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.